Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long Term Effects of Hintonia Latiflora Extract in Type 2 Diabetes
NCT00315718Phase 3Completed
- Sponsor
- Harras Pharma Curarina
- Start
- Jun 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Hintonia latiflora extract in type 2 diabetes mellitus (T2DM), sponsored by Harras Pharma Curarina. Primary endpoint: Hemoglobin A1c at 36 months. Started Jun 2002; status: completed.
02
Drugs
Hintonia latiflora extract
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00315718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00315718.